Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2012

Antzeko izenburuak